← Back to Agios Pharmaceuticals
Revision of Agios Pharmaceuticals
syncWikidata syncChanges
| Field | Before | After |
|---|---|---|
| Description | — | Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. |
| Type | — | organization |